BUCHAREST (Romania), February 2 (SeeNews) – Austria's Erste Group said on Wednesday it downgraded its recommendation for Romanian drug maker Biofarm [BSE:BIO] to 'hold' from 'accumulate' and raised the target price for its stock by 4.6%.